Singapore, Feb. 16 -- The World Health Organization (WHO) hasprequalified an additional novel oral polio vaccine type 2 (nOPV2), further strengthening the global supply of a vaccine at the heart of efforts to stop poliovirus type 2 outbreaks more sustainably and accelerate progress towards polio eradication.

The newly prequalified product is manufactured by BiologicalE.Limited (BioE), India, using in-house bulk vaccine following a technology transfer from PT Bio Farma (Persero), Indonesia. This prequalification builds on earlier WHO listings of nOPV2 manufactured by PT BioFarma, as well asthe vaccine formulated and filled by BioE using bulk supplies from PT Bio Farma.

With this latest addition, WHO continues to diversify and strengthen ...